“D” Is for Diagnosis: Decoding a Difficult Thoracic Malignancy – Piecing Together a Rare Diagnosis, Preparing for Tomorrow’s Treatments

January 14, 2026

Countdown to Event

00

Days

00

Hours

00

Mins

00

Secs

Overview:

Despite increasing awareness and new therapeutic options, malignant pleural mesothelioma (MPM) remains difficult to diagnose and manage. Nonspecific symptoms, imaging overlap, and variable biopsy yield contribute to delayed identification, while evolving immunotherapy-based strategies require thoughtful patient selection and coordinated multidisciplinary care.

This live webcast “D” Is for Diagnosis: Decoding a Difficult Thoracic Malignancy – Piecing Together a Rare Diagnosis, Preparing for Tomorrow’s Treatments will immerse learners in an interactive case that simulates real diagnostic challenges, followed by expert discussion translating findings into practical management. Faculty will highlight how to streamline diagnostic workflows, apply current first-line IO-IO and IO-chemotherapy options, and anticipate emerging approaches including bispecifics. The program equips clinicians with concise, actionable strategies to improve timely diagnosis and evidence-based treatment of MPM.

Learning Objectives:

Upon completion of this activity, participants will be able to:

  • Apply a structured algorithm for patient evaluation, including selection of appropriate IHC/ancillary tests, to accurately diagnose malignant pleural mesothelioma (MPM)
  • Evaluate new evidence supporting frontline options and emerging therapies for MPM
  • Integrate the latest data into personalized treatment plans based on patient characteristics
  • Describe roles of the multidisciplinary care team in the collaborative management of MPM